INVITED LECTURES+
ERIC/EBMT recommendations on allogeneic stem cell transplantation in CLL (Montserrat, Dreger, Current Hematologic Malignancy Reports 2015)
INVITED LECTURES+
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study (Rawstron, Leukemia, 2016)
Improving efficiency and sensitivity: ERIC update on the international harmonised approach for flow cytometric residual disease monitoring in CLL (Rawstron, Leukemia, 2013)
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia (Rawstron, Leukemia 2007)
INVITED LECTURES+
ERIC recommendations on TP53 mutation analysis in CLL – Update on methodological approaches and results interpretation (Pospisilova, Leukemia 2018)
ERIC recommendations on TP53 mutation analysis in Chronic Lymphocytic Leukemia (Pospisilova, Leukemia 2012)
INVITED LECTURES+
Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: The 2022 Update of the Recommendations by ERIC, the European Research Initiative on CLL (Agathangelidis, Leukemia 2022)
Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: Updated ERIC recommendations (Rosenquist, Leukemia 2017)
ERIC recommendations for IGHV gene mutational analysis in CLL for problematic cases (Langerak, Leukemia 2011)
ERIC recommendations for IGHV gene mutational analysis in CLL (Ghia, Leukemia 2007)
INVITED LECTURES+
Expert-based consensus supported by ASH and ERIC, athe EHA SWG on CLL
Allogeneic Stem Cell Transplant+
ERIC/EBMT recommendations on allogeneic stem cell transplantation in CLL (Montserrat, Dreger, Current Hematologic Malignancy Reports 2015)
Minimal Residual Disease Detection+
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study (Rawstron, Leukemia, 2016)
Improving efficiency and sensitivity: ERIC update on the international harmonised approach for flow cytometric residual disease monitoring in CLL (Rawstron, Leukemia, 2013)
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia (Rawstron, Leukemia 2007)
TP53 Aberrations+
ERIC recommendations on TP53 mutation analysis in CLL – Update on methodological approaches and results interpretation (Pospisilova, Leukemia 2018)
ERIC recommendations on TP53 mutation analysis in Chronic Lymphocytic Leukemia (Pospisilova, Leukemia 2012)
Inmunoglobin Gene Analysis+
Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: The 2022 Update of the Recommendations by ERIC, the European Research Initiative on CLL (Agathangelidis, Leukemia 2022)
Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: Updated ERIC recommendations (Rosenquist, Leukemia 2017)
ERIC recommendations for IGHV gene mutational analysis in CLL for problematic cases (Langerak, Leukemia 2011)
ERIC recommendations for IGHV gene mutational analysis in CLL (Ghia, Leukemia 2007)
COVID-19 AND CLL: FAQS+
Expert-based consensus supported by ASH and ERIC, athe EHA SWG on CLL
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.